IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06604533 Brief Summary The aim of this study is to investigate…
Read more arrow_forwardACTRN 12619000288123 Brief Introduction This study aims to evaluate the safety and…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardACTRN 12623000959673 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 06840119 Brief Summary This phase 1/2 first-in-human study is designed to…
Read more arrow_forwardNCT 04106492 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05280314 Brief Summary This is a multicenter, multi-arm trial evaluating anti-tumor…
Read more arrow_forward